SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950116-03-004008
Filing Date
2003-10-03
Accepted
2003-10-03 16:18:57
Documents
1
Period of Report
2003-10-03

Document Format Files

Seq Description Document Type Size
1 PRE 14A pre14-a.txt PRE 14A 47260
  Complete submission text file 0000950116-03-004008.txt   48787
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-25169 | Film No.: 03928130
SIC: 2834 Pharmaceutical Preparations